Neal I. Muni, MD, MSPH
Dr. Muni joined CutisPharma as President in July 2014 and was named Chief Executive Officer in May 2015. Prior to joining CutisPharma, Dr. Muni served as the head of Corporate Strategy at Sunovion Pharmaceuticals. Prior to joining Sunovion, Dr. Muni worked as a consultant in the healthcare investment bank Leerink Swann, LLC. Prior to that, Dr. Muni was a Medical Officer in the Division of Cardiovascular Devices at the FDA, serving as the lead medical reviewer for coronary drug-eluting stents. Dr. Muni practiced as an Internist with the Hospitalist Group of the Department of Medicine at Brigham and Women’s Hospital and Harvard Medical School for over 15 years, completing his residency at the Brigham and Women’s Hospital in Internal Medicine. He received his M.D. as well as Master of Science in Public Health, from the Tulane School of Medicine, and a B.A. in Business Economics and B.Sc. in Biochemistry from Brown University.